Clinical Trials

Breast Neoplasms

NCT02856503 2026-04-17

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

Phase 1/2 Withdrawn

Phase 1/2 Active not recruiting

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02917421 2026-04-17

ART

88 enrolled 10 charts

Breast Neoplasms

NCT03495115 2026-04-17

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Phase NA Completed

460 enrolled 4 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT03971409 2026-04-17

InCITe

145 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04174742 2026-04-17

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

115 enrolled

Breast Neoplasms, Pain

NCT04889924 2026-04-17

ADARNAT

820 enrolled

Phase 1 Active not recruiting

Breast Neoplasms, Radiation Injuries

NCT05081492 2026-04-17

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

9 enrolled

Triple Negative Breast Neoplasms

NCT05488145 2026-04-17

A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

Phase NA Terminated

21 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT05570253 2026-04-17

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

55 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05704062 2026-04-17

Quantitative MRI Assessment of Breast Cancer Therapy Response

135 enrolled

Breast Neoplasms

NCT06042569 2026-04-17

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

174 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT06195709 2026-04-17

ECLECTIC

Phase 3 Recruiting

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT06427226 2026-04-17

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

46 enrolled

Breast Neoplasms

NCT06492759 2026-04-17

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

29 enrolled

Triple Negative Breast Neoplasms

NCT06823440 2026-04-17

CIPN

100 enrolled

Breast Neoplasms

NCT07191496 2026-04-17

Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

Terminated

30 enrolled

Breast Cancer Survivor

NCT07253987 2026-04-17

SURV-QoL

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07285993 2026-04-17

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

15 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07294703 2026-04-17

Factors Associated With Breast Cancer Risks and Outcomes

750 enrolled

Breast Neoplasms

NCT07400523 2026-04-17

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

446 enrolled

Breast Neoplasms

NCT07504770 2026-04-17

Surgical Glove

84 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07536867 2026-04-17

SPSIP-RIB

50 enrolled

Breast Neoplasms, Pain, Postoperative

NCT07537712 2026-04-17

PPTOX-BC

Not yet recruiting

750 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT02744053 2026-04-16

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Triple Negative Breast Neoplasms

NCT02918474 2026-04-16

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

15 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

34 enrolled

Phase 1 Active not recruiting

Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

18 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT04003038 2026-04-16

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

80 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT04085276 2026-04-16

TORCHLIGHT

Phase 3 Completed

531 enrolled

Phase NA Active not recruiting

Triple Negative Breast Neoplasms

NCT04125914 2026-04-16

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

384 enrolled

BreastGastrointestinal

Breast Cancer, Familial, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

Phase NA Active not recruiting

40 enrolled 9 charts

Breast Neoplasms

NCT05056818 2026-04-16

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics

750 enrolled

Breast Neoplasms

NCT05534438 2026-04-16

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

46 enrolled

Breast Neoplasms

NCT05749588 2026-04-16

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

120 enrolled

Triple Negative Breast Neoplasms

NCT05876390 2026-04-16

IRACPoP

Enrolling by invitation

1,500 enrolled

Breast Neoplasms, Pain, Postoperative

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

60 enrolled

Anatomic Stage III Breast Cancer AJCC v8

NCT06545682 2026-04-16

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Phase 1 Recruiting

50 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06681064 2026-04-16

BELIEVE

500 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06964802 2026-04-16

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

30 enrolled

Breast Neoplasms

NCT07011654 2026-04-16

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Phase 1/2 Recruiting

31 enrolled

Triple Negative Breast Neoplasms

NCT07425548 2026-04-16

JOUVENCE

22 enrolled

Breast Neoplasms

NCT07447414 2026-04-16

LUBRECA

140 enrolled

Breast Neoplasms

NCT07467824 2026-04-16

PREACT

66 enrolled

Breast Neoplasms, Motor Activity

NCT07475923 2026-04-16

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Withdrawn

Breast Neoplasms

NCT07491380 2026-04-16

TDHOME

90 enrolled

Breast Neoplasms

NCT07533526 2026-04-16

Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study

40 enrolled

Breast Neoplasms, Pain

NCT00477100 2026-04-15

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

1,200 enrolled